Imiquimod 3.75% Cream Applied Daily to Treat Anogenital Warts: Combined Results from Women in Two Randomized, Placebo-Controlled Studies
Figure 3
Partial clearance rates and change in wart count from baseline. White: placebo, stippled: imiquimod 2.5%, solid black: imiquimod 3.75%. (a) Partial (≥75% reduction in wart count compared to baseline) clearance rates, PP. values from a Cochran-Mantel-Haenszel test, stratified by analysis site using two treatment groups at a time.*indicates statistically significant for active versus placebo, and †for imiquimod 3.75% versus 2.5%, using Hochberg's modified Bonferroni procedure. Bars indicate 95% confidence interval calculated using exact method. (b) Change in wart count compared with baseline, mean percent, PP. values from an analysis of covariance test, controlling for baseline wart count and analysis site.*indicates statistically significant for active versus placebo, and †for imiquimod 3.75% versus 2.5%, using Hochberg's modified Bonferroni procedure.
